OLMA
Olema Pharmaceuticals Inc
8.30$
+0.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.2% | +0.0% | +6.8% | +1.1% | +22.1% | +10.3% | +3.1% | -67.4% | +334.9% | -36.4% | -14.3% | – | |
| – | +6.0% | +12.8% | +16.6% | -1.7% | +12.4% | -30.8% | +7.2% | -9.4% | +0.4% | +137.9% | +27.1% | – | |
| – | – | -21.7% | -123.9% | – | -38.4% | -848.3% | – | -57.9% | -6.4% | -153.0% | – | – | |
| – | – | – | -96.1% | +2,550.0% | -100.0% | – | – | – | – | – | – | – | |
| – | +21.5% | -34.8% | -75.8% | – | -349.2% | -60.6% | – | -49.5% | -1,038.9% | – | +801.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.6% | +1,586.6% | +76.9% | -99.4% | +265,443.5% | -99.9% | -1,234.2% | – | +520,758.5% | -78.6% | -97.6% | – | |
| – | -159.3% | – | – | – | +445.3% | -185.8% | – | -1,039.1% | – | -67.4% | -193.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.